Free Trial

Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics logo
$1.62 +0.06 (+3.85%)
Closing price 04:00 PM Eastern
Extended Trading
$1.63 +0.01 (+0.86%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BJDX vs. CODX, SSKN, LFWD, TNON, ICU, POAI, SINT, LUCY, STRR, and STSS

Should you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Co-Diagnostics (CODX), Strata Skin Sciences (SSKN), Lifeward (LFWD), Tenon Medical (TNON), SeaStar Medical (ICU), Predictive Oncology (POAI), SINTX TECHNOLOGIES (SINT), Innovative Eyewear (LUCY), Star Equity (STRR), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

Bluejay Diagnostics vs. Its Competitors

Bluejay Diagnostics (NASDAQ:BJDX) and Co-Diagnostics (NASDAQ:CODX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

Bluejay Diagnostics has a net margin of 0.00% compared to Co-Diagnostics' net margin of -1,025.45%. Co-Diagnostics' return on equity of -60.16% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bluejay DiagnosticsN/A -322.46% -262.96%
Co-Diagnostics -1,025.45%-60.16%-52.69%

Co-Diagnostics has a consensus target price of $5.50, suggesting a potential upside of 1,807.73%. Given Co-Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Co-Diagnostics is more favorable than Bluejay Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bluejay Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Co-Diagnostics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00

18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 15.0% of Co-Diagnostics shares are held by institutional investors. 0.1% of Bluejay Diagnostics shares are held by insiders. Comparatively, 8.4% of Co-Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Bluejay Diagnostics has higher earnings, but lower revenue than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluejay Diagnostics$250K9.66-$7.72M-$379.740.00
Co-Diagnostics$3.91M2.48-$37.64M-$1.17-0.25

In the previous week, Bluejay Diagnostics' average media sentiment score of 0.00 equaled Co-Diagnostics'average media sentiment score.

Company Overall Sentiment
Bluejay Diagnostics Neutral
Co-Diagnostics Neutral

Bluejay Diagnostics has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, Co-Diagnostics has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Summary

Co-Diagnostics beats Bluejay Diagnostics on 10 of the 15 factors compared between the two stocks.

Get Bluejay Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BJDX vs. The Competition

MetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.33M$6.68B$5.57B$9.43B
Dividend YieldN/A1.30%4.05%3.99%
P/E Ratio0.0025.4528.0520.08
Price / Sales9.6664.03428.2394.45
Price / CashN/A20.2736.1958.45
Price / Book0.164.798.605.83
Net Income-$7.72M$176.14M$3.24B$258.27M
7 Day Performance0.62%3.29%4.63%3.98%
1 Month Performance1.25%6.65%12.93%14.89%
1 Year Performance-94.58%6.66%35.40%19.29%

Bluejay Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BJDX
Bluejay Diagnostics
0.4866 of 5 stars
$1.62
+3.8%
N/A-95.0%$2.33M$250K0.009
CODX
Co-Diagnostics
3.7916 of 5 stars
$0.28
+1.4%
$5.50
+1,840.7%
-76.8%$9.38M$3.91M-0.24100High Trading Volume
SSKN
Strata Skin Sciences
2.6581 of 5 stars
$2.21
+0.5%
$6.00
+171.5%
-37.8%$9.18M$33.56M0.00120
LFWD
Lifeward
1.9477 of 5 stars
$0.74
+1.1%
$9.00
+1,119.5%
-79.4%$8.04M$25.41M-0.2460
TNON
Tenon Medical
1.5384 of 5 stars
$1.14
+8.1%
$4.67
+309.4%
+74.7%$8.01M$3.28M-0.048
ICU
SeaStar Medical
0.4156 of 5 stars
$0.68
-4.1%
N/A-88.8%$7.95M$140K-0.202
POAI
Predictive Oncology
2.2824 of 5 stars
$0.79
-0.6%
$3.00
+282.1%
-27.5%$7.06M$1.62M-0.2630
SINT
SINTX TECHNOLOGIES
2.9655 of 5 stars
$2.78
+0.4%
$28.00
+907.2%
-47.4%$6.95M$2.89M-0.0540News Coverage
LUCY
Innovative Eyewear
0.1078 of 5 stars
$2.18
+3.8%
N/A-54.7%$6.50M$1.64M-0.559
STRR
Star Equity
3.5359 of 5 stars
$2.04
+2.9%
$5.00
+144.8%
-57.8%$6.37M$53.36M-0.60460
STSS
Sharps Technology
1.0154 of 5 stars
$6.31
+9.4%
N/AN/A$5.88MN/A0.003

Related Companies and Tools


This page (NASDAQ:BJDX) was last updated on 7/23/2025 by MarketBeat.com Staff
From Our Partners